Abstract:Copper is an essential trace element in the human body, participating in a variety of biological functions and metabolic processes. The homeostatic copper in the human body is regulated by the absorption, transportation, storage, and metabolism of copper. Dysregulation of copper metabolism is closely related to the occurrence and progression of various diseases. The cell death induced by copper overload is initiated by interaction between copper and acylated enzymes in the tricarboxylic acid (TCA) cycle, which then results in protein aggregation, loss of iron‐sulfur cluster proteins, and cell death. Furthermore, we discuss the role of copper in regulating autophagy, the relationship between copper‐dependent death and disease, and the potential role of copper in cancer treatment. We emphasize the necessity for further research into alternative pathways of copper‐induced cell death, the detailed mechanisms of Cuproptosis, and biomarkers for copper poisoning. It proposes future research directions, including exploring the molecular mechanisms of Cuproptosis, developing new therapeutic strategies, and verifying their safety and efficacy in clinical trials. Background Copper is an essential trace element for biological systems, as it plays a critical role in the activity of various enzymes and metabolic processes. However, the dysregulation of copper homeostasis is closely associated with the onset and progression of numerous diseases. In recent years, copper‐induced cell death, a novel form of cellular demise, has garnered significant attention. This process is characterized by the abnormal accumulation of intracellular copper ions, leading to cellular dysfunction and eventual cell death. Copper toxicity occurs through the interaction of copper with acylated enzymes in the tricarboxylic acid (TCA) cycle. This interaction results in subsequent protein aggregation, causing proteotoxic stress and ultimately resulting in cell death. Despite the promise of these findings, the detailed mechanisms and broader implications of cuproptosis remain underexplored. Therefore, our study aimed to investigate the role of copper in cell death and autophagy, focusing on the molecular mechanisms of cuproptosis. We also aimed to discuss recent advancements in copper‐related research across various diseases and tumors, providing insights for future studies and potential therapeutic applications. Main Body This review delves into the biological significance of copper metabolism and the molecular mechanisms underlying copper‐induced cell death. Furthermore, we discuss the role of copper toxicity in the pathogenesis of various diseases, emphasizing recent advancements in the field of oncology. Additionally, we explore the therapeutic potential of targeting copper toxicity. Conclusion The study highlights the need for further research to explore alternative pathways of copper‐induced cell death, detailed mechanisms of cuproptosis, and biomarkers for copper poisoning. Future research should focus on exploring the molecular mechanisms of cuproptosis, developing new therapeutic strategies, and verifying their safety and efficacy in clinical trials.

Metal ions overloading and cell death

From ferroptosis to cuproptosis, and calcicoptosis, to find more novel metals-mediated distinct form of regulated cell death

Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death

The crosstalk between mitochondrial quality control and metal-dependent cell death

Exogeneous Metal Ions As Therapeutic Agents in Cardiovascular Disease and Their Delivery Strategies.

Oxidative mechanisms in the toxicity of metal ions

Copper-instigated modulatory cell mortality mechanisms and progress in oncological treatment investigations

Mitochondrial Metal Ion Transport in Cell Metabolism and Disease

Restoration of metal homeostasis: a potential strategy against neurodegenerative diseases

[Metal element homeostasis and oxidative stress in pathological processes].

Effects of Intracellular Iron Overload on Cell Death and Identification of Potent Cell Death Inhibitors

Intervention Strategies for Metal Deficiency and Overload

A Focus on Mesenchymal Stem/Stromal Cell Differentiation

Iron overload and programmed bone marrow cell death: Potential mechanistic insights

Metal ions and degenerative diseases

Disruption of the superoxide anions-mitophagy regulation axis mediates copper oxide nanoparticles-induced vascular endothelial cell death

Nanoenabled Intracellular Metal Ion Homeostasis Regulation for Tumor Therapy

Cuproptosis: Mechanisms, biological significance, and advances in disease treatment—A systematic review

Current understanding of metal ions in the pathogenesis of Alzheimer’s disease

The interplay of transition metals in ferroptosis and pyroptosis

Metalloimmunology: The metal ion-controlled immunity